Arbutus Biopharma (0SGC.LSE) Q2 2024 Earnings

2MayConfirmed
Q4 2023
Q2 2024
-0.12
-0.11
-0.11
-0.1

Details

Expected EPS
-0.11
Actual EPS
-0.1
Surprise EPS
0.01
Surprise Percent
+9.09%

Description

Arbutus Biopharma (0SGC.LSE) has reported earnings of -0.1 per share for Q2 2024.

0 Comments

Share your thoughts